Tevogen Bio Inc.
TVGN | NASDAQ
$5.79
-$0.11 (-1.86%)
Nov 2, 2026, 12:25 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
PE Ratio | -2.05 | -11 | -27.8K | 281.47 | -30.12 |
PEG Ratio | -0.03 | 0 | 275 | -2.53 | n/a |
PS Ratio | n/a | n/a | n/a | n/a | n/a |
PB Ratio | -6.68 | -22.64 | -19.48 | -36.51 | -28.90 |
P/FCF Ratio | -4.44 | -12.59 | -221.51 | -135.70 | -88.48 |
P/OCF Ratio | -4.46 | -12.59 | -225.12 | -143.21 | -90.32 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | -0.38 | -0.43 | -1.01 | -1.18 | -1.42 |
Quick Ratio | 0.22 | 0.26 | 0.02 | 2.98 | 10.74 |
Current Ratio | 0.22 | 0.26 | 0.02 | 2.98 | 10.74 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -133.63 | -291.05 | -34.54 | n/a | -7.72 |
Return on Equity | 319.08% | 151.55% | 64.05% | -12.98% | 94.59% |
Return on Assets | -599.49% | -292.18% | -1.1K% | 56.96% | -203.66% |
Return on Invested Capital | 3.7K% | 1.45K% | -892.63% | -15.74% | -66.07% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove TVGN